Lyophilization Technology for

COVID-19 Vaccines

Freeze-Drying of Liquid Vaccines to Produce Stable, Rapidly Dissolving Powders

図4.jpeg
 
図1.png

About our Technology

We are adapting our patented continuous lyophilization (freeze-drying) technology to the production of vaccines. 

Originally developed for the production of sterile injectables, we have changed our focus and are now pursuing the production of sterile, room temperature stable powder vaccines. 

We are actively searching for partners who are experts and pioneers in the research and development of novel vaccines so that we can take on the challenge of producing powdered vaccines made via the latest technology.

 

Progress through Innovation

building4.png

Factory Construction

Layout and Schedule
(Startup planned for Mid 2022)

Research Collaboration

Learn about how we can work together

research.jpg
S__33546251.jpg

Contract Manufacturing

Freeze-dry your vaccines with our facilities & equipment